BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12722525)

  • 1. [Antiretroviral treatment of HIV infected patients].
    Lichterfeld M; Rockstroh JK
    Med Monatsschr Pharm; 2003 Apr; 26(4):111-21; quiz 121-2. PubMed ID: 12722525
    [No Abstract]   [Full Text] [Related]  

  • 2. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
    Sabin CA
    J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates.
    Manfredi R
    Int J STD AIDS; 2010 Jan; 21(1):73-4. PubMed ID: 19843616
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleoside analogues and HIV: the combined cost to mitochondria.
    Cherry CL; Wesselingh SL
    J Antimicrob Chemother; 2003 May; 51(5):1091-3. PubMed ID: 12668570
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment: treatment of acute HIV infection--uncertainties about best practice.
    Kassutto S; Rosenberg ES
    AIDS Read; 2005 May; 15(5):250-1. PubMed ID: 15900635
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?
    Laurence J
    AIDS Read; 2001 Feb; 11(2):64-5. PubMed ID: 11279873
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interactions. Introduction: careful combinations.
    TreatmentUpdate; 2006; 18(3):1-2. PubMed ID: 17209235
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients.
    Fernández Cotarelo MJ; Abellán Martínez J; Guerra Vales JM; Martínez Sánchez P; Rodrigo Gómez De La Bárcena M; Salto Fernández E
    Clin Infect Dis; 2003 Oct; 37(7):973-7. PubMed ID: 13130410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in HIV treatment: the 3rd International AIDS Society Conference.
    Boyle BA
    AIDS Read; 2005 Oct; 15(10):552-7. PubMed ID: 16265770
    [No Abstract]   [Full Text] [Related]  

  • 13. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 14. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):56-8. PubMed ID: 19280746
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Diaz-Linares M; Vázquez E
    Posit Aware; 2008; 19(1):50-2. PubMed ID: 18546578
    [No Abstract]   [Full Text] [Related]  

  • 19. Information from your family doctor. How to take your medicines for HIV.
    Am Fam Physician; 2003 Aug; 68(4):689-90. PubMed ID: 12952385
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination antiretroviral therapy.
    Domingo P; Vidal F
    Expert Opin Pharmacother; 2011 May; 12(7):995-8. PubMed ID: 21434758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.